NNUMBER |
COMPETENCIES |
DOMAIN |
LEVEL |
CORE |
SUGGESTED TEACHING LEARNING METHOD |
SUGGESTED ASSESSMENT METHOD |
NUMBER REQUIRED TO CERTIFY P |
VERTICAL INTEGRATION |
HORIZONTAL INTEGRATION |
|
PRINCILPLES OF RADIATION ONCOLOGY |
|
|
|
|
|
|
|
|
RT1.1 |
Describe and discuss defination of Radiation, mechanism of action, types
of radiation |
K |
KH |
Y |
Lecture |
Written/Viva |
1 |
|
|
|
Learning Objectives |
|
|
|
|
|
|
|
|
objective 1 |
At the end of session the phase III Student must be able to define
Radiaion correctly |
K |
KH |
Y |
|
|
|
|
|
objective 2 |
At the end of session the phase III Student must know different types
of Radiation |
K |
KH |
Y |
|
|
|
|
|
Objective 3 |
At the end of session the phase III student must describe the Electromagnetic
Radiation |
|
|
|
|
|
|
|
|
Objective 4 |
At the end of session of the phase III student must be able to describe
the Particulate Radiation |
|
|
|
|
|
|
|
|
Objective 5 |
At the end of session of the phase III student must be able to define
the mode of action of Radiation |
K |
KH |
Y |
|
|
|
|
|
Objective 6 |
At the end of session of the phase III student must be able to describe
the Direct Action of radiation |
|
|
|
|
|
|
|
|
Objective 7 |
At the end of session of the phase III student must be able to describe
the indirect action of Radiation |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
RT1.2 |
Describe and discuss interection of Radiation with matter and measurement
of radiation |
K |
KH |
Y |
Lecture |
Written/Viva |
|
|
|
|
Objectives |
|
|
|
|
|
|
|
|
objective 1 |
At the end of session of the phase III student must be able to describe
Ionization |
K |
KH |
Y |
|
|
|
|
|
objective 2 |
At the end of session of the phase III student must be able to describe
photon beam attenuation |
K |
KH |
Y |
|
|
|
|
|
objective 3 |
At the end of session of the phase III student must know different
types of photon beam interation with matter |
K |
KH |
Y |
|
|
|
|
|
objective 4 |
At the end of session of the phase III student must know interaction
of charged particles with matter |
K |
KH |
Y |
|
|
|
|
|
objective 5 |
At the end of session of the phase III student must know interaction
of neutrons with matter |
K |
KH |
Y |
|
|
|
|
|
objective 6 |
At the end of session of the phase III student must know how to measurement
of exposure |
K |
KH |
Y |
|
|
|
|
|
objective 7 |
At the end of session of the phase III student must know Beam
Quality |
K |
KH |
Y |
|
|
|
|
|
objective 8 |
At the end of session of the phase III student must know methods of
measurement of absorbed dose |
K |
KH |
Y |
|
|
|
|
|
Objective 9 |
At the end of session the phase III student must be able to describe
Rontgen to Rad conversion factor |
|
|
|
|
|
|
|
|
RT1.3 |
Enumerate, describe and discuss Classification and Staging of Cancer |
K |
KH |
Y |
Lecture |
Written/Viva |
|
|
|
|
Objectives |
|
|
|
|
|
|
|
|
objective 1 |
At the end of session of the phase III student must be able to classify
Cancer based on tissue type |
K |
KH |
Y |
|
|
|
|
|
objective 2 |
At the end of session of the phase III student must know about FIGO
staging |
K |
KH |
Y |
|
|
|
|
|
objective 3 |
At the end of session of the phase III student must know in which cancers
FIGO staging is used |
K |
KH |
Y |
|
|
|
|
|
objective 4 |
At the end of session of the phase III student must know about TNM
staging /Stage grouping |
K |
KH |
Y |
|
|
|
|
|
objective 5 |
At the end of session of the phase III student must know about T staging
in TNM staging |
K |
KH |
Y |
|
|
|
|
|
objective 6 |
At the end of session of the phase III student must know about N staging
in TNM staging |
K |
KH |
Y |
|
|
|
|
|
objective 7 |
At the end of session of the phase III student must know about M staging
in TNM staging |
|
|
|
|
|
|
|
|
|
RADIATION PROTECTION |
|
|
|
|
|
|
|
|
RT2.1 |
Describe and discuss radiation protection and personal monitoring during
Radiation Treatment |
K |
KH |
Y |
Lecture |
Written/Viva |
|
|
|
|
Objectives |
|
|
|
|
|
|
|
|
objective 1 |
At the end of session of the phase III student must be able to define
Maximum Permissible dose of Radiation |
K |
KH |
Y |
|
|
|
|
|
objective 2 |
At the end of session of the phase III student must know permisible
Dose levels for publc |
|
|
|
|
|
|
|
|
objective 3 |
At the end of session of the phase III student must permisible Dose levels
for workers |
|
|
|
|
|
|
|
|
objective 4 |
At the end of session of the phase III student must be able to describe
Principles of radiation protection |
K |
KH |
Y |
|
|
|
|
|
objective 5 |
At the end of session of the phase III student must know the Shielding
in Radiation |
|
|
|
|
|
|
|
|
objective 6 |
At the end of session of the phase III student must know the Units
of Radiation |
|
|
|
|
|
|
|
|
objective 7 |
At the end of session of the phase III student must know about TLD
badge |
|
|
|
|
|
|
|
|
objective 8 |
At the end of session of the phase III student must know about Film
badge |
K |
KH |
Y |
|
|
|
|
|
objective 9 |
At the end of session of the phase III student must know about Pocket
dosimeter |
K |
KH |
Y |
|
|
|
|
|
Objective 10 |
At the end of session of phase III student must know about qulity factor
and dose equivalent of different Radiation types |
K |
KH |
Y |
|
|
|
|
|
|
|
K |
KH |
Y |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
RADIOBIOLOGY AND CHEMORADIATION |
|
|
|
|
|
|
|
|
RT3.1 |
Describe and discuss cell cycle and cell survival curve, principles of
Radiobiology |
K |
KH |
Y |
Lecture |
Written/Viva |
|
|
|
|
Objectives |
|
|
|
|
|
|
|
|
objective 1 |
At the end of session of the phase III student must be able to describe
cell cycle and its stages |
K |
KH |
Y |
|
|
|
|
|
objective 2 |
At the end of session of the phase III student must be able to define
Cell survival curve (CSC) |
K |
KH |
Y |
|
|
|
|
|
objective 3 |
At the end of session of the phase III student must know the Effects
of different types of radiation on CSC |
|
|
|
|
|
|
|
|
objective 4 |
At the end of session of the phase III student must Effects of Oxygenation
on CSC |
|
|
|
|
|
|
|
|
objective 5 |
At the end of session of the phase III student must know the mechanism
of radiation damage and repair mechanisms |
K |
KH |
Y |
|
|
|
|
|
objective 6 |
At the end of session of the phase III student must be able to describe
the Four R's of Radiobilogy |
K |
KH |
Y |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
RT3.2 |
Describe and discuss synergism of radiation and chemotherapy |
K |
KH |
Y |
Lecture |
Written/Viva |
|
|
|
|
Objectives |
|
|
|
|
|
|
|
|
objective 1 |
At the end of session of the phase III student must be able to describe
Theraputic Index |
K |
KH |
Y |
|
|
|
|
|
objective 2 |
At the end of session of the phase III student must be able to describe
the Strategies of combining Chemotherapy and Radiotherapy |
K |
KH |
Y |
|
|
|
|
|
objective 3 |
At the end of session of the phase III student must be able descibe the
Principles of Chemoradiation |
|
|
|
|
|
|
|
|
objective 4 |
At the end of session of the phase III student must be able
to describe Independent Toxicity,spacial co-operation,normal tissue radiation
and enhancement of effects of radiation |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
RADIATION TREATMENT DELIVERY AND OUTCOME |
|
|
|
|
|
|
|
|
RT4.1 |
Describe and discuss teletherapy machines (Co60, LINAC) |
K |
KH |
Y |
Lecture/Video/DOAP |
Written/Viva |
|
|
|
|
Objectives |
|
|
|
|
|
|
|
|
objective 1 |
At the end of session of the phase III student must be able to describe
Cobalt 60 machine |
K |
KH |
Y |
|
|
|
|
|
objective 2 |
At the end of session of the phase III student must be able to describe
Cobalt Source |
|
|
|
|
|
|
|
|
objective 3 |
At the end of session of the phase III student must be able to describe
Source Housing |
|
|
|
|
|
|
|
|
objective 4 |
At the end of session of the phase III student must be able to describe
Beam Collimation |
|
|
|
|
|
|
|
|
objective 5 |
At the end of session of the phase III student must be able to describe
Penumbra |
|
|
|
|
|
|
|
|
objective 6 |
At the end of session of the phase III student must be able to describe
LINAC machine |
K |
KH |
Y |
|
|
|
|
|
objective 7 |
At the end of session of the phase III student must be able to describe
. Magnetron |
|
|
|
|
|
|
|
|
objective 8 |
At the end of session of the phase III student must be able to describe
Klystron |
|
|
|
|
|
|
|
|
objective 9 |
At the end of session of the phase III student must be able to describe
Electron Beam |
|
|
|
|
|
|
|
|
objective 10 |
At the end of session of the phase III student must be able to describe
X-ray Beam |
|
|
|
|
|
|
|
|
objective 11 |
At the end of session of the phase III student must be able to describe
Treatment Head |
|
|
|
|
|
|
|
|
objective 12 |
At the end of session of the phase III student must be able to describe
Beam Collimation |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
RT4.2 |
Enumerate, Describe and discuss types of treatment plan, basic work flow
of 2D/3DCRT/IMRT/IGRT |
K |
KH |
Y |
Lecture/DOAP |
Written/Viva |
|
|
|
|
Objectives |
|
|
|
|
|
|
|
|
objective 1 |
At the end of session of the phase III student must able to enumerate
types of treatment plan |
K |
KH |
Y |
|
|
|
|
|
objective 2 |
At the end of session of the phase III student must know the Prerequisets
of treatment plan |
K |
KH |
Y |
|
|
|
|
|
objective 3 |
At the end of session of the phase III student must know the radiotherapy
treatment Planning process |
K |
KH |
Y |
|
|
|
|
|
objective 4 |
At the end of session of the phase III student must know Conventional
Plan (2D) |
|
|
|
|
|
|
|
|
objective 5 |
At the end of session of the phase III student must know Conformal
Plan (3D,IMRT,IGRT) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
RT 4.3 |
Describe and discuss Brachytherapy Machine |
K |
KH |
Y |
Lecture/DOAP |
Written/Viva |
|
|
|
|
Objectives |
|
|
|
|
|
|
|
|
objective 1 |
At the end of session of the phase III student must able to Define Brachytherapy
(BT) |
K |
KH |
Y |
|
|
|
|
|
objective 2 |
At the end of session of the phase III student must know the Types
of Brachytherapy |
K |
KH |
Y |
|
|
|
|
|
objective 3 |
At the end of session of phase III student must able to describe different
Brachytherapy machine in Radiotherapy |
K |
KH |
Y |
|
|
|
|
|
objective 4 |
At the end of session of the phase III student must know about Manual
Afterloading BT |
K |
KH |
Y |
|
|
|
|
|
objective 5 |
At the end of session of the phase III student must know about Remote
Afterloading BT |
|
|
|
|
|
|
|
|
RT4.4 |
Describe and discuss different Radioactive isotopes and their use in
cancer patients |
K |
KH |
Y |
Lecture |
Written/Viva |
|
|
|
|
Objectives |
|
|
|
|
|
|
|
|
objective 1 |
At the end of session of the phase III student must able to Enumerate
commonly used radioactive isotopes |
K |
KH |
Y |
|
|
|
|
|
objective 2 |
At the end of session of the phase III student must able to describe
Physical properties of Radioactive isotopes |
K |
KH |
Y |
|
|
|
|
|
objective 3 |
At the end of session of the phase III student must know Uses of these
radioactive isotopes in cancer |
K |
KH |
Y |
|
|
|
|
|
|
|
K |
KH |
Y |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
RT4.5 |
Describe and discuss role of radiation in management of common malignancies
in India (Region specific) |
K |
KH |
Y |
Lecture/Group Discussion/DOAP |
Written/Viva |
|
|
|
|
Objectives |
|
|
|
|
|
|
|
|
objective 1 |
At the end of session of the phase III student must know Role of radiation
in management of Cervical Cancer |
K |
KH |
Y |
|
|
|
|
|
objective 2 |
At the end of session of the phase III student must knowRole of radiation
in management of Breast Cancer |
K |
KH |
Y |
|
|
|
|
|
objective 3 |
At the end of session of the phase III student must knowRole of Radiation
inmanagement of Head and Neck Cancer |
K |
KH |
Y |
|
|
|
|
|
objective 4 |
At the end of session of the phase III student must knowRole of Radiation
in management of Lung Cancerr |
K |
KH |
Y |
|
|
|
|
|
objective 5 |
At the end of session of the phase III student must know side effect
of Radiation Therapy |
k |
kh |
|
|
|
|
|
|
RT4.6 |
Describe and discuss Radiotherapy for Benign diseases |
K |
KH |
Y |
Lecture |
Written/Viva |
|
|
|
|
Objectives |
|
|
|
|
|
|
|
|
objective 1 |
At the end of session of the phase III student must able toEnumerate
the benign neoplasms treated with Radiotherapy |
K |
KH |
Y |
|
|
|
|
|
objective 2 |
At the end of session of the phase III student must knowRadiobiologic
effect on benign diseases |
K |
KH |
Y |
|
|
|
|
|
objective 3 |
At the end of session of the phase III student must knowIndications of
Radiotherapy in benign diseases |
K |
KH |
Y |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
RT4.7 |
Counsel patients regarding Acute and Late effects of Radiation and Supportive
Care |
K |
KH |
Y |
Lecture/Group Discussion |
Written/Viva |
|
|
|
|
Objectives |
|
|
|
|
|
|
|
|
objective 1 |
At the end of session of the phase III student must know Salivary gland
injury and Xerostomia |
K |
KH |
Y |
|
|
|
|
|
objective 2 |
At the end of session of the phase III student must know the Mucosal
injury |
K |
KH |
Y |
|
|
|
|
|
objective 3 |
At the end of session of the phase III student must know Skin injury |
K |
KH |
Y |
|
|
|
|
|
objective 4 |
At the end of session of the phase III student must know Genitourinary
tract side effects |
K |
KH |
Y |
|
|
|
|
|
objective 5 |
At the end of session of the phase III student must know Supportive
care for side effects of Radiation |
K |
KH |
Y |
|
|
|
|
|
objective 6 |
At the end of session of the phase III student must know Supportive Care
for Prevention of Radiation toxicity |
K |
KH |
Y |
|
|
|
|
|
objective 7 |
At the end of session of the phase III student must able to describe
Acute and Late Side effects of radiotherapy |
|
|
|
|
|
|
|
|
RT4.8 |
Describe Oncologic Emergencies and Palliative Care |
K |
KH |
Y |
Lecture/Group discussion |
Written/Viva |
|
|
|
|
Objectives |
|
|
|
|
|
|
|
|
objective 1 |
At the end of session of the phase III student must able to enneumerate
the oncologic Emergencies |
K |
KH |
Y |
|
|
|
|
|
objective 2 |
At the end of session of the phase III student must able to describe
Raised Intracranial pressure |
K |
KH |
Y |
|
|
|
|
|
objective 3 |
At the end of session of the phase III student must able to describe
Metbolic Complications |
K |
KH |
Y |
|
|
|
|
|
objective 4 |
At the end of session of the phase III student must able to describeTumor
lysis Syndrome |
|
|
|
|
|
|
|
|
objective 5 |
At the end of session of the phase III student must able to describe
Hypercalcemia |
|
|
|
|
|
|
|
|
objective 6 |
At the end of session of the phase III student must able to describe
Spinal Cord Compression |
K |
KH |
Y |
|
|
|
|
|
objective 7 |
At the end of session of the phase III student must able to define
Palliative Care |
|
|
|
|
|
|
|
|
objective 8 |
At the end of session of the phase III student must able to describe
Palliative Care for Cancer Pain Management |
K |
KH |
Y |
|
|
|
|
|
objective 9 |
At the end of session of the phase III student must able to describe
WHO Ladder based Pain Management. |
K |
KH |
Y |
|
|
|
|
|
objective 10 |
At the end of session of the phase III student must able to describeSuperior
Venacava Syndrome |
|
|
|
|
|
|
|
|
objective 11 |
At the end of session of phase III student must able to use of Morphine
for pain management in palliative care |
K |
KH |
Y |
|
|
|
|
|
objective 12 |
At the end of session of the phase III student must able to describe
Communicating news |
K |
KH |
Y |
|
|
|
|
|
objective 13 |
At the end of session of the phase III student must able to describe
total pain management in palliative care seting |
K |
KH |
Y |
|
|
|
|
|
objective 14 |
At the end of session of the phase III student must know the different
dilevery system of palliative care |
K |
KH |
Y |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
RT4.9 |
Display empathy in the care of patient with cancer |
A |
SH |
N |
Lecture/Group Discussion |
|
|
|
Objectives |
|
|
|
|
|
|
|
|
objective 1 |
At the end of session of the phase III student must know Meaning of
empathy |
A |
SH |
N |
|
|
|
|
|
objective 2 |
At the end of session of the phase III student able to practise Good
coommunication skill |
A |
SH |
N |
|
|
|
|
|
objective 3 |
At the end of session of the phase III student mustCommunicating with
family and other professionals |
A |
SH |
N |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
CANCER PREVENTION AND REGESTRATION |
|
|
|
|
|
|
|
|
RT5.1 |
Describe and discuss cancer prevention, screening, vaccination and cancer
regestration |
K |
KH |
Y |
Lecture/DOAP |
Written/Viva |
|
|
|
|
Objectives |
|
|
|
|
|
|
|
|
objective 1 |
At the end of session of the phase III student must be able enneumerete
the ways of cancer prevention |
K |
KH |
Y |
|
|
|
|
|
objective 2 |
At the end of session of the phase III student must able to describe
Tobacco use and cancer prevention |
K |
KH |
Y |
|
|
|
|
|
objective 3 |
At the end of session of the phase III student must able to describe
Tobacco cesassion programme |
K |
KH |
Y |
|
|
|
|
|
objective 4 |
At the end of session of the phase III student must able to Describe
cancer risk reducing agents including vaccines |
K |
KH |
Y |
|
|
|
|
|
objective 5 |
At the end of session of the phase III student must be able to Define
screening |
K |
KH |
Y |
|
|
|
|
|
objective 6 |
At the end of session of the phase III student must be able describe
the screening ca breast, cervix .and oral cavity |
K |
KH |
Y |
|
|
|
|
|
objective 7 |
At the end of session of the phase III student must know Objectives
and type of Cancer Regestration |
|
|
|
|
|
|
|
|
objective 8 |
At the end of session of the phase III student must be able to perform
CBE and Pap test know Objectives |
K |
KH |
Y |
|
|
|
|
|
objective 9 |
At the end of session of the phase III student must be able to identify
premalignent lesion. |
K |
KH |
Y |
|
|
|
|
|
objective 10 |
At the end of session of the phase III student must know Cancer Regestration
in India |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
ORTHOPAEDICS |
|
|
|
|
|
|
|
|
RT6.1 |
Describe and discuss the etiopathogenesis, clinical features, investigations
and principles of management of benign and malignant bone tumors and pathological
fracture |
K |
KH |
Y |
Lecture/Group Discussion |
Written/Viva |
|
|
|
|
Objectives |
|
|
|
|
|
|
|
|
objective 1 |
Describe and discuss the etiopathogenesis, clinical features, investigations
and principles of management of Osteosarcoma |
K |
KH |
Y |
|
|
|
|
|
objective 2 |
Describe and discuss the etiopathogenesis, clinical features, investigations
and principles of management of Ewing Sarcoma |
K |
KH |
Y |
|
|
|
|
|
objective 3 |
Describe and discuss the etiopathogenesis, clinical features, investigations
and principles of management of Chondrosarcoma |
K |
KH |
Y |
|
|
|
|
|
objective 4 |
Describe and discuss the etiopathogenesis, clinical features, investigations
and principles of management of Bone metastasis |
K |
KH |
Y |
|
|
|
|
|